View an enhanced version of our Annual Report.
View an enhanced version of our Proxy Statement.
Request paper copies of the above proxy materials online now, by email or by phone by dialing 866-648-8133.
Please vote your proxy online now or by phone by dialing
866-428-0096.
June 11, 2026
1:30 PM PT
You must register to be eligible to participate in the meeting.
Janux Therapeutics is a clinical-stage company developing precision-engineered immunotherapies that have the potential to generate potent and durable immune responses without causing systemic safety issues. Janux is using its TRACTr, TRACIr and ARM platforms to engineer novel drug candidates that are designed to overcome the traditional limitations associated with contemporary immunotherapies. As a biotechnology company based in San Diego, Janux is an active part of a vibrant and growing biotech ecosystem.